Streptococcus pneumoniae antigen in urine: Diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients

Respirology

Volumn 19, Issue 6, 2014, Pages 936-943

  Zalacain, Rafael ^a   Capelastegui, Alberto ^b   Ruiz, Luis Alberto ^a   Bilbao, Amaia ^c   Gomez, Ainhoa ^a   Uranga, Ane ^b   España, Pedro P ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

Author keywords

bacteraemic pneumococcal pneumonia; community acquired pneumonia; outcome; sensitivity; urinary pneumococcal antigen

Indexed keywords

ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS PNEUMONIAE ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BIOLOGICAL MARKER;

ADULT; ADULT DISEASE; ADVERSE OUTCOME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTERIAL OXYGEN TENSION; ARTICLE; BACTERAEMIC PNEUMOCOCCAL PNEUMONIA; BREATHING RATE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCOMPETENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PH; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROTYPE; STREPTOCOCCUS PNEUMONIA; TREATMENT DURATION; TREATMENT FAILURE; URINE; AGED; BACTEREMIA; EVALUATION STUDY; IMMUNOLOGY; LONGITUDINAL STUDY; PNEUMONIA, PNEUMOCOCCAL; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTEREMIA; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE;

EID: 84904577627     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12341     Document Type: Article

References (31)

1. Bartlett JG,. Diagnostic tests for agents of community-acquired pneumonia. Clin. Infect. Dis. 2011; 52 (Suppl. 4): S296-304.
2. Blaschke AJ,. Interpreting assays for the detection of Streptococcus pneumoniae. Clin. Infect. Dis. 2011; 52 (Suppl. 4): S331-337.
3. Domínguez J, Gali N, Blanco S, Pedroso P, Prat C, Matas L, Ausina V,. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 2001; 119: 243-249.
4. Murdoch DR, Laing RTR, Mills GD, Karalus NC, Town GI, Mirrett S, Reller LB,. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J. Clin. Microbiol. 2001; 39: 3495-3498.
5. Marcos MA, Jiménez de Anta MT, de la Bellacasa JP, González J, Martínez E, García E, Mensa J, de Roux A, Torres A,. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur. Respir. J. 2003; 21: 209-214.
6. Gutiérrez F, Masía M, Rodríguez JC, Ayelo A, Soldán B, Cebrián L, Mirete C, Royo G, Hidalgo AM,. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin. Infect. Dis. 2003; 36: 286-292.
7. Rosõn B, Fernández-Sabé N, Carratalá J, Verdaguer R, Dorca J, Manresa F, Gudiol F,. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin. Infect. Dis. 2004; 38: 222-226.
8. Smith MD, Sheppard CL, Hogan A, Creek M, Morris R, Dance DAB, Cartwright K,. Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. J. Clin. Microbiol. 2009; 47: 1046-1049.
9. Sordé R, Falcõ V, Lowak M, Domingo E, Ferrer A, Burgos J, Puig M, Cabral E, Len O, Pahissa A,. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch. Intern. Med. 2011; 171: 166-172.
10. Rueda AM, Serpa JA, Matioobi M, Mushtaq M, Musher DM,. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore) 2010; 89: 331-336.
11. Fine MJ, Auble TE, Yealy DM, Hanusa DH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN,. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997; 336: 243-250.
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement. M100-S18. CLSI, Wayne, PA, 2008.
13. Weinberge DM, Harboe ZB, Sanders EAM, Ndiritu M, Klugman KP, Ruckinger S, Dagan R, Adeqbola R, Cutts F, Johnson HL, et-al. Risk of death from pneumococcal pneumonia is a stable serotype-associated property: a meta-analysis. Clin. Infect. Dis. 2010; 51: 692-699.
14. Ménendez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F,. Community-acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch. Bronconeumol. 2010; 46: 543-558.
15. Levy MM, Fink M, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G,. SCCM/ESICM/ATS/SIS international sepsis definitions conference. Crit. Care Med. 2003; 31: 1250-1256.
16. Menéndez R, Torres A, Zalacain R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, et-al. Risk factors of treatment failure in community-acquired pneumonia: implications for disease outcome. Thorax 2004; 59: 960-965.
17. España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM,. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2006; 174: 1249-1256.
18. Garnacho-Montero J, García-Cabrera E, Diaz-Martin A, Lepe-Jimenez JA, Iraurgui-Arcarazo P, Jiménez-Alvárez R, Revuelto-Rey J, Aznar-Martín J,. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand. J. Infect. Dis. 2010; 42: 185-192.
19. Luján M, Gallego M, Fontanals D, Mariscal D, Rello J,. Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality. Crit. Care Med. 2004; 32: 625-631.
20. García-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Liñares J, Gudiol F, Carratalá J,. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010; 65: 77-81.
21. Yu VL, Chiou CCC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, et-al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered and clinical outcome. Clin. Infect. Dis. 2003; 37: 230-237.
22. Cilloniz C, Torres A,. Understanding mortality in bacteremic pneumococcal pneumonia. J. Bras. Pneumol. 2012; 38: 419-421.
23. Boulware DR, Daley CL, Merrifield C, Hopewell PC, Janoff EN,. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J. Infect. 2007; 55: 300-309.
24. Perellõ R, Mirõ O, Marcos MA, Almela M, Bragulat E, Sánchez M, Agustí C, Mirõ JM, Moreno A,. Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED. Am. J. Emerg. Med. 2010; 28: 454-459.
25. Tateda K, Kusano E, Matsumoto T, Kimura K, Uchida K, Nakata K, Yamaguchi K,. Semi-quantitative analysis of Streptococcus pneumoniae urinary antigen: kinetics of antigen titers and severity of disease. Scand. J. Infect. Dis. 2006; 38: 166-171.
26. Peters RPH, de Boer RF, Schuurman T, Gierveld S, Kooistra-Smid M, van Agtmel MA, Vandenbroucke-Grauls CMJE, Persoons MCJ, Savelkoul PHM,. Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia. J. Clin. Microbiol. 2009; 47: 3308-3312.
27. Rello J, Lisboa T, Lujan M, Gallego M, Kee C, Kay I, Lõpez D, Waterer GW,. Severity of pneumococcal pneumonia associated with genomic bacterial pneumonia. Chest 2009; 136: 832-840.
28. Ramírez P, Ferrer M, Martí V, Reyes S, Martínez R, Menéndez R, Ewig S, Torres A,. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit. Care Med. 2011; 39: 2211-2217.
29. Selickman J, Paxos M, File TM, Seltzern R, Bonilla H,. Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia. Diagn. Microbiol. Infect. Dis. 2010; 67: 129-133.
30. Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, Marco MA, Torres A, Mensa J,. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower mortality for patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 2003; 36: 289-295.
31. Yu VL,. A clinical solution to antimicrobial resistance in community-acquired pneumonia. Narrowing the spectrum of antimicrobial therapy. Arch. Intern. Med. 2011; 171: 172-173.